Dive Brief:
- Healthcare remains the AI industry's biggest vertical, with health AI investments ballooning to $3.7 billion — more than double the past year, according to a new Menlo Partners report.
- Provider organizations are looking to deploy AI in new areas, with the most popular ones being front-office operations and clinical copilots, the report shows.
- Even though established health IT companies continue to dominate the ambient scribing space, providers are increasingly turning to startups for AI-driven clinical and administrative tools.
Dive Insight:
The report findings show that provider interest is going beyond ambient scribing, which is one of the most popular use cases for AI in healthcare.
AI tools that address administrative tasks, including ambient scribing and coding and billing, continue to be popular, but healthcare AI is also expanding into other areas. These include more complex workflows like clinical decision support, drug discovery and patient interactions, which were traditionally relegated to humans, the report authors wrote.
The report, which polled over 550 U.S. healthcare and life sciences executives, reveals that year-over-year growth was less than double for ambient scribing and coding and billing. Meanwhile, AI uses such as clinical copilots that assist providers with patient care and patient engagement/front office functions grew approximately five-fold to $550 million and $450 million, respectively. Clinical copilots and patient engagement are the biggest AI growth areas for providers, which is notable as providers account for the bulk (77%) of healthcare AI spend.
These also represent areas in which providers seem willing to move away from incumbent health IT vendors, the survey revealed.
While over two-thirds of providers would rather keep coding, billing and chart review within their EHR, only 16% said the same for patient navigation.
But for other uses, respondents are open to AI startups.
OpenEvidence is the most popular choice for clinical copilots, although recent deals could bring other clinical decision-making tools to the forefront in the future. Utah's regulatory sandbox, for instance, has allowed Doctronic to process prescription renewals for 191 medications.
Even ARPA-H is investing $62.7 million to create 24/7 AI agents that can monitor heart failure patients between visits, with the intention of the AI becoming FDA-approved.
Still, when it comes to ambient scribing, AI startups are ceding ground to incumbent health IT companies. In 2026, legacy vendors, such as Microsoft's Dragon Copilot and Epic's Art, took 68% of new ambient scribing dollars. These companies now hold 46% market share.
At the same time, AI startups lost 13% of market share, pushing some of them to expand outside of ambient scribing. Abridge has recently struck a deal with Availity to create real-time prior authorization, the report said, while Heidi has partnered with R1 to integrate payer prior authorization policies into the clinical encounter.